Symbols

USNA

Usana Health Sciences·NYSE

--(--)

USNA fundamentals

USNA Q4 2025 Earnings

Usana Health Sciences (USNA) released its earnings on Feb 18, 2026: revenue was 226.20M (YoY +5.89%), beat estimates; EPS was 0.6 (YoY -6.25%), beat estimates.

Revenue / YoY

226.20M

+5.89%

EPS / YoY

0.6

-6.25%

Report date

Feb 18, 2026

USNA Earnings Call Summary for Q4,2025

FY2026 Growth Target: 4% net sales growth, driven by Hiya and Rise Wellness expansion.
Strategic Focus: Omnichannel technology, personalized nutrition, and in-house manufacturing.
Financial Highlights: $35M inventory build for growth ventures, 55-60% effective tax rate.
Key Risks: Seasonal revenue fluctuations, thin margins for new ventures.
Opportunities: AI integration, global retail partnerships (Target, Costco).

Earnings

EPS

Revenue

Revenue & Expenses

USNA has released its 2025 Q4 earnings report, with revenue of 226.20M, reflecting a YoY change of 5.89%, and net profit of -1.59M, showing a YoY change of -135.57%. The Sankey diagram below clearly presents USNA's revenue sources and cost distribution.

Key Indicators

Usana Health Sciences (USNA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Usana Health Sciences (USNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Usana Health Sciences (USNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Usana Health Sciences (USNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown